Recent News

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: The Debate Continues

Successful Treatment of Rare Case of Urothelial Carcinoma of the Fossa Navicularis

Independent Risk Factors of Bladder Cancer: Perspective From an Iranian Province

Predicting Pathologic Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

Can a Centralized, Multidisciplinary Program Improve Outcomes in Muscle-Invasive Bladder Cancer?

Can Sugary Drinks Increase Bladder Cancer Risk?

Risk of Bladder Cancer After Ranitidine Exposure: Danish Population-Based Study

Prevalence of Depression and Risk Factors in Elderly Patients With Bladder Cancer

SITC 2021: Preclinical Study of Microbial Immunotherapy in Bladder Cancer

Vaccine Plus Pembrolizumab Under Study in Non–Muscle-Invasive Bladder Cancer

Patients With Bladder Cancer and a Smoking History: Can Urinary pH Predict Recurrence?

Can Smoking-Related DNA Methylation Markers Help to Predict Urothelial Cancer Risk?

How Many Cycles of Cisplatin-Based Chemotherapy Before Cystectomy Is Enough?

Non–Muscle-Invasive Disease: BCG With or Without Novel Vaccine Tested in Phase II Trial

Radical Cystectomy: Comparing Outcomes by Stage and Type of Bladder Cancer

Subsequent Chemotherapy for Metastatic Urothelial Carcinoma: Is Platinum-Based Therapy of Benefit?

3-Year Outcomes With Perioperative Chemotherapy Regimen for Muscle-Invasive Bladder Cancer

Nectin-4 Expression and Prognosis in Upper Tract Urothelial Cancer

Do Antibiotics Impact the Efficacy of Pembrolizumab in Metastatic Urothelial Carcinoma?

Preoperative Chemotherapy for Muscle-Invasive Bladder Cancer: Is Age Related to Response?

AUA 2021: Antibody Levels as Predictors of Response to Immunotherapy in Bladder Cancer

AUA 2021: Trial Update on Novel Gene-Mediated Therapy for High-Grade Bladder Cancer

ESMO 2021: Erdafitinib Plus Cetrelimab in Advanced Urothelial Carcinoma With FGFR Alterations

AUA 2021: Interim Analysis of Novel Immunotherapy for BCG-Unresponsive Bladder Cancer

ESMO 2021: Bladder Preservation in Older Patients With Muscle-Invasive Bladder Cancer

AUA 2021: Long-Term Analysis of UGN-101 in Upper Tract Urothelial Carcinoma

AUA 2021: Initial Study Findings With Large Surface Area Microparticle Docetaxel in Bladder Cancer

Is Aspirin Intake Associated With Risk of Bladder Cancer or Its Prognosis?

Muscle-Invasive Bladder Cancer: Comparing Trimodal Therapy and Radical Cystectomy

Pembrolizumab Receives Full FDA Approval for Certain Patients With Advanced Urothelial Carcinoma

Novel Approach to Detecting PD-L1 in the Urine of Patients With Bladder Cancer

FDA Approves Nivolumab as First Adjuvant Treatment for High-Risk Urothelial Carcinoma

Can Dietary Tomato Intake Influence the Risk of Bladder Cancer?

Urothelial Carcinoma: Prognostic Factors Associated With Immune Checkpoint Inhibitors

Atezolizumab in Resistant Advanced Urothelial Cancer: Prognostic Significance of Pretreatment Factors

Adding Atezolizumab to Chemotherapy for Muscle-Invasive Bladder Cancer

Update From EV-103: Enfortumab Vedotin-ejfv Plus Pembrolizumab for Advanced Urothelial Carcinoma